title: Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence.
abstract: Nonalcoholic fatty liver disease (NAFLD) is widely emerging as the most prevalent liver disorder and is associated with increased risk of liver-related and cardiovascular mortality. Recent experimental and clinical studies have revealed the pivotal role played by the alteration of gut-liver axis in the onset of fatty liver and related metabolic disturbances. Gut-liver cross talk is implicated not only in the impairment of lipid and glucose homeostasis leading to steatogenesis, but also in the initiation of inflammation and fibrogenesis, which characterize nonalcoholic steatohepatitis (NASH), the evolving form of NAFLD. The gut microbiota has been recognized as the key player in the gut-liver liaison and because of its complexity can act as a villain or a victim. Gut microbiota not only influences absorption and disposal of nutrients to the liver, but also conditions hepatic inflammation by supplying toll-like receptor ligands, which can stimulate liver cells to produce proinflammatory cytokines. Thus, the modification of intestinal bacterial flora by specific probiotics has been proposed as a therapeutic approach for the treatment of NASH. In this review, we summarized the evidence regarding the role of gut-liver axis in the pathogenesis of NASH and discussed the potential therapeutic role of gut microbiota modulation in the clinical setting.
authors: Division of Hepatogastroenterology, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
authors: Alessandro
authors: A
authors: Federico
authors: Division of Hepatogastroenterology, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
authors: Marcello
authors: M
authors: Dallio
authors: Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
authors: Justyna
authors: J
authors: Godos
authors: Division of Hepatogastroenterology, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
authors: Carmela
authors: C
authors: Loguercio
authors: Division of Gastroenterology, Ospedale di Acireale, Azienda Sanitaria Provinciale di Catania, Catania, Italy. Electronic address: federicosalomone@rocketmail.com.
authors: Federico
authors: F
authors: Salomone
mesh_terms: D000069196:Gastrointestinal Microbiome; D006801:Humans; D007249:Inflammation; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000382:microbiology; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D065626:Non-alcoholic Fatty Liver Disease / Q000209:etiology / Q000378:metabolism / Q000628:therapy*